A comprehensive view of BioNTech SE. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

BioNTech and Ryvu Therapeutics enter into global collaboration to develop and commercialize immuno-modulatory small molecule candidates focused on oncology; Ryvu receives €20.0M in exchange for certain rights to its STING agonist portfolio

BioNTech SE listed a new clinical trial to learn about bivalent COVID-19 RNA vaccine candidate(s) in healthy infants and children

CEOs of BioNTech, Bayer, Merck KGaA join German Chancellor Scholz in high-profile China visit

Australia: BioNTech SE Owns Trademark for 'BIONTECH' and '3 HORIZONTAL STRIPES FORM LTR E'

United States Patent for Individualized Vaccines for Cancer Issued to Biontech SE and Tron Translationale Onkologie an Der Univ Der Johannes Gutenberg Univ Mainz Ggmbh

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count